Ajax-Loading

Astellas Pharma Inc. - Other Long Term Liabilities

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Other-Long-Term-Liabilities" stands at 53.57 Billion Japanese Yens as of 03/31/2025, the highest value at least since 06/30/2019, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.41 percent compared to the value the year prior.
The 1 year change in percent is 9.41.
The 3 year change in percent is 36.53.
The 5 year change in percent is 106.03.

The Serie's long term average value is 35.93 Billion Japanese Yens. It's latest available value, on 03/31/2025, is 49.07 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2020, to it's latest available value, on 03/31/2025, is +126.88%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 03/31/2025, is 0.0%.

Other Long Term Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Long Term Liabilities905,699,262,464.00
LogoJohnson & Johnson - Other Long Term Liabilities486,508,953,600.00
LogoAbbVie Inc - Other Long Term Liabilities399,570,305,024.00
LogoRoche Holding AG - Other Long Term Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Other Long Term Liabilities280,205,508,085.11